HomeINBX • NASDAQ
add
Inhibrx Biosciences Inc
Previous close
$15.33
Day range
$15.16 - $16.09
Year range
$10.80 - $39.79
Market cap
224.67M USD
Avg Volume
117.16K
P/E ratio
0.13
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 100.00K | 233.33% |
Operating expense | 93.37M | 1,185.50% |
Net income | 1.86B | 4,048.85% |
Net profit margin | 1.86M | 1,284.65% |
Earnings per share | — | — |
EBITDA | -160.42M | -290.84% |
Effective tax rate | 0.00% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 226.86M | — |
Total assets | 258.42M | — |
Total liabilities | 39.05M | — |
Total equity | 219.37M | — |
Shares outstanding | 14.48M | — |
Price to book | 1.01 | — |
Return on assets | -280.66% | — |
Return on capital | -376.91% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 1.86B | 4,048.85% |
Cash from operations | -80.09M | -44.82% |
Cash from investing | -1.22M | -283.28% |
Cash from financing | 30.24M | 217.45% |
Net change in cash | -51.06M | 37.25% |
Free cash flow | -57.90M | — |
About
Founded
2024
Headquarters
Website
Employees
173
